Status:

UNKNOWN

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome

Lead Sponsor:

Sociedad Española de Neumología y Cirugía Torácica

Collaborating Sponsors:

Fondo de Investigacion Sanitaria

Fundacion Caubet-Cimera Islas Baleares

Conditions:

Sleep Apnea

Cardiovascular Diseases

Eligibility:

MALE

25-65 years

Phase:

NA

Brief Summary

The objective of the study is to define and compare clotting- fibrinolysis patterns, platelet function markers and endothelial dysfunction in patients with SAHS before and after treatment and normal c...

Detailed Description

The hypothesis of the study is the following: Patients with sleep apnea-hypopnea syndrome have higher risk of cardiovascular mortality during the night. Respiratory alterations (hypoxia, hypoxia- reo...

Eligibility Criteria

Inclusion

  • Apnea-Hypopnea Index \> 15

Exclusion

  • Presence of any chronic disease
  • Presence of cardiovascular disease
  • Refusal to sign informed consent
  • Drug addiction and/or alcoholism
  • Any medication two weeks before

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00456287

Start Date

February 1 2007

Last Update

April 4 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hospital Universitario Son Dureta

Palma de Mallorca, Balearic Islands, Spain, 07014

Platelet Activation and Circadian Rhythms of Clotting-Fibrinolysis Factors in Patients With Sleep Apnea Syndrome | DecenTrialz